Contact information
Rosie Bradley
BSc, MSc
Medical Statistician
Rosie is a Medical Statistician in the Clinical Trial Service Unit (CTSU). Prior to joining in 2012, she studied Applied Statistics at the University of Plymouth (BSc) and Biometry at the University of Reading (MSc). She is currently involved in randomised trials in neurodegenerative diseases and is working on meta-analyses of breast cancer trials in EBCTCG.
Recent publications
-
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Journal article
Howard R. et al, (2019), JAMA Neurol
-
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
-
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trial.
Journal article
Forsyth K. et al, (2019), Alzheimers Dement (N Y), 5, 420 - 430
-
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Journal article
Howard R. et al, (2018), Health Technol Assess, 22, 1 - 62
-
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Journal article
Howard R. et al, (2018), Lancet Psychiatry, 5, 553 - 563